Jamese Brown News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Larsucosterol Gets Breakthrough Tx Status for Alcohol-Associated Hepatitis

The designation was supported by data from the double-blind, placebo-controlled phase 2b AHFIRM trial.

Jamese brownDrug administrationBreakthrough therapyEuropean associationLiver congress

Durect s hope for people with alcohol-related hepatitis

Durect s hope for people with alcohol-related hepatitis
outsourcing-pharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from outsourcing-pharma.com Daily Mail and Mail on Sunday newspapers.

Jamese brownDurect corporationBreakthrough therapyEuropean associationFast trackEnd stage liver disease

FDA Grants Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis

The primary outcome was a 90-day incidence of mortality or liver transplant for individuals who received larsucosterol, compared to the placebo group.

Danil nikonovJamese brownCorporation receivesNational library of medicineNational libraryTherapy designationMore than halfNot awareLink between alcohol

DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript

DURECT Corporation (NASDAQ:DRRX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesJamese brownCarl byrnesJim brownTimothym pappEd arceFrancois briseboisFrank briseboisThomas yipTim pappOppenheimer coDurect corporationDurect corpCorporation first quarterCall transcript may

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update

DURECT Corporation Reports First Quarter 2024 Financial Results and Business Update
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesJamese brownInnocoll pharmaceuticals ltdCorporation nasdaqCompany phaseInnocoll pharmaceuticalsDrug administrationExchange commissionSupports single pivotal trialEarnings call todayNew drug applicationEuropean associationFast track designationAlcohol associated hepatitisEnd stage liver diseasePrivate securities litigation reform act